We found that targeted deletion of STK10 in prostate cancer cells could promote cell proliferation and inhibit cell apoptosis via inhibiting the activity of p38 MAPK, and that it suppressed cell migration through inhibiting ERM proteins activation [7]. This evidence concerns the gene STK10 and prostate carcinoma.